Corrao G, Arico S, Carle F, Russo R, Galatola G, Tabone M, Torchio P, De la Pierre M, Di Orio F
Department of Internal Medicine and Public Health, University of L'Aquila, Italy.
Rev Epidemiol Sante Publique. 1991;39(4):333-43.
We carried out a hospital based case-control study involving 655 patients with chronic liver disease encompassing chronic hepatitis, asymptomatic liver cirrhosis and symptomatic liver cirrhosis and 655 pair-matched control individuals in order to estimate the dose-response relationship between alcohol consumption and the occurrence of chronic liver disease. Alcohol intake was measured by a questionnaire and expressed as Daily Alcohol Intake (DAI) during the patient life. DAI estimates from patient interviews were in good agreement with those obtained by interviewing a sample of relatives. We found an exponential positive association between DAI and the risk of chronic hepatitis and cirrhosis. However, consuming less than 100g of alcohol every day did not increase the risk of developing chronic liver disease. For asymptomatic cirrhosis the risk was lower than for chronic hepatitis, especially at high DAI, probably because high consumption carried a high probability of liver decompensation. For symptomatic cirrhosis, the risk function showed a similar pattern as for chronic hepatitis. Chronic hepatitis patients were 6-7 years younger than cirrhotics. Our results suggest that the evolution towards cirrhosis once a chronic liver damage has occurred is probably time-dependent, but not or minimally dependent on alcohol intake.
我们开展了一项基于医院的病例对照研究,纳入了655例慢性肝病患者,包括慢性肝炎、无症状肝硬化和有症状肝硬化患者,并纳入了655名配对对照个体,以评估酒精摄入量与慢性肝病发生之间的剂量反应关系。酒精摄入量通过问卷调查进行测量,并表示为患者一生中的每日酒精摄入量(DAI)。通过对患者访谈得出的DAI估计值与通过对亲属样本访谈获得的估计值高度一致。我们发现DAI与慢性肝炎和肝硬化风险之间呈指数正相关。然而,每天饮酒量少于100克并不会增加患慢性肝病的风险。对于无症状肝硬化,其风险低于慢性肝炎,尤其是在高DAI水平时,可能是因为高饮酒量导致肝失代偿的可能性很高。对于有症状肝硬化,风险函数显示出与慢性肝炎相似的模式。慢性肝炎患者比肝硬化患者年轻6 - 7岁。我们的结果表明,一旦发生慢性肝损伤,向肝硬化的进展可能与时间有关,但与酒精摄入量无关或仅有极小的关联。